tiprankstipranks
Minerva Neurosciences (NERV)
NASDAQ:NERV
Holding NERV?
Track your performance easily

Minerva Neurosciences (NERV) Stock Investors

567 Followers
Based on 768,736 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NERV
On average, investors allocate 0.00% of their portfolios to NERV
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 768,736 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NERV

1.8%
Last 7
Days
6.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NERV, out of 768,736 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NERV Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,681 investors who made their portfolios public
The table shows changes in NERV in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NERV Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
4.56%
-0.06%
+6.29%
5.53B
Healthcare
DraftKings
5.36%
-0.92%
+0.84%
35.08B
Consumer Cyclical
Plug Power
5.22%
-1.05%
-0.65%
1.70B
Industrials
Bristol-Myers Squibb
3.54%
-0.91%
-1.77%
114.02B
Healthcare
Abbott Laboratories
3.56%
+0.37%
+11.31%
201.02B
Healthcare
Carnival
6.43%
+0.31%
+7.74%
30.46B
Consumer Cyclical
Li Auto
5.57%
-1.61%
-4.23%
22.34B
Consumer Cyclical
RTX
4.10%
-0.18%
+7.38%
157.77B
Industrials
Block
4.37%
+1.89%
+3.51%
51.87B
Technology
CVS Health
3.92%
+0.18%
-0.23%
66.93B
Healthcare
Based on the activity of 768,736 active portfolios
Open your Smart Portfolio

NERV Investor Analysis

NERV investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
23.4%
of NERV holders
are under 35
Average Segment Performance
Average P/E Ratio29.47
Beta10.82
Dividend Yield99.38%
NERV investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
51.9%
of NERV holders
are between 35–55
Average Segment Performance
Average P/E Ratio26.86
Beta20.87
Dividend Yield46.37%
NERV investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
24.7%
of NERV holders
are over 55
Average Segment Performance
Average P/E Ratio25.26
Beta9.51
Dividend Yield77.60%
Overview of age group and performance of NERV stock investors
See who invests in NERV according to age group and performance.

FAQ

How many retail Investors hold NERV?
<0.1% of TipRanks' retail investors hold NERV in their portfolios.
    What is NERV Investor Sentiment?
    NERV’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of NERV in the last 7 days?
      ▼ 1.8% of TipRanks' retail investors changed their holding of NERV in the last 7 days.
        What percentage of retail investors changed their holding of NERV in the last 30 days?
        ▼ 6.1% of TipRanks' retail investors changed their holding of NERV in the last 30 days.
          What is the average age of retail investors who hold NERV?
          The average age of NERV Holders is between 35–55.
            What other stocks have NERV investors also bought?
            NERV Investors also bought VKTX, DKNG, PLUG, BMY, ABT, CCL, LI, RTX, SQ, CVS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              CNCCentene
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis